FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and is intended for impact on microcirculation in bone tissue in case of experimental osteoporosis and fractures at its background. Method includes modelling osteoporosis in female rats of Wistar line by bilateral ovariectomy and osteoporotic fractures and pharmacological correction of pathological states with L-norvalin in dose 10 mg/kg intragastrically, daily, one time per day.
EFFECT: application of claimed invention makes it possible to prevent negative dynamics of indices of microcirculation in bone tissue in case of osteoporosis and in bone callus in case of osteoporotic fractures.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CORRECTING MICROCIRCULATION IN BONE TISSUE WITH COMBINATION OF L-NORVALIN AND ROSUVASTATIN IN CASE OF EXPERIMENTAL OSTEOPOROSIS AND FRACTURES AT ITS BACKGROUND | 2013 |
|
RU2540927C1 |
| METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING OSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND LOSARTAN | 2013 |
|
RU2542425C1 |
| METHOD FOR CORRECTING BONE MICROCIRCULATION ACCOMPANYING EXPERIMENTALOSTEOPOROSIS AND UNDERLYING FRACTURES WITH USE OF COMBINATION OF L-ARGININE AND ENALAPRIL | 2013 |
|
RU2542424C1 |
| METHOD FOR CORRECTION OF BONE TISSUE MICROCIRCULATON IN EXPERIMENTAL OSTEOPOROSIS AND ASSOCIATED FRACTURES WITH COMBINATION OF RECOMBINANT ERYTHROPOIETIN AND ROSUVASTATIN | 2013 |
|
RU2541184C1 |
| METHOD FOR ROSUVASTATIN CORRECTION OF BONE MICROCIRCULATION IN EXPERIMENTAL OSTEOPOROSIS AND ACCOMPANYING FRACTURES | 2013 |
|
RU2538612C1 |
| METHOD FOR RECOMBINANT ERYTHROIETIN CORRECTION OF BONE TISSUE MICROCIRCULATION ACCOMPANYING SIMULATED OSTEOPOROSIS AND ASSOCIATED FRACTURES | 2013 |
|
RU2541181C1 |
| METHOD FOR THE CORRECTION OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 3-HYDROXY-2-ETHYL-6-METHYLPYRIDINIUM NICOTINATE IN EXPERIMENT | 2021 |
|
RU2763011C1 |
| METHOD FOR CORRECTING OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM HYDROXYBUTANEDIOATE IN EXPERIMENT | 2021 |
|
RU2775439C1 |
| METHOD FOR RESERVATROL AND ENALAPRIL BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437160C1 |
| METHOD FOR RESERVATROL-BASED OSTEOPOROSIS CORRECTION AND FRAGILITY FRACTURE PREVENTION | 2010 |
|
RU2437161C1 |
